Answers are grounded in this paper and cite their sources.
Lung cancer is one of the leading causes of cancer-related mortality worldwide. Understanding the molecular mechanisms underlying lung cancer progression is critical for identifying novel therapeutic targets. This study investigated the role and regulatory mechanism of the EZH2/miR-152/HK2 axis in lung cancer development. The expression levels of miR-152, EZH2, and HK2 were analyzed in lung cancer tissues and cells. Gain- and loss-of-function experiments were performed to evaluate their effects on glycolysis, cell proliferation, migration, and tumor growth. Target interactions were validated using molecular assays, and survival analyses were conducted to assess clinical relevance. MiR-152 expression was significantly decreased in lung cancer tissues, and higher miR-152 levels were associated with improved patient survival. Overexpression of miR-152 inhibited glucose metabolism, cell proliferation, migration, and tumor growth. HK2 was identified as a direct target of miR-152. EZH2 was markedly upregulated in lung cancer and correlated with poor prognosis. EZH2 knockdown suppressed lung cancer cell proliferation and invasion. Mechanistically, EZH2 epigenetically repressed miR-152 expression, thereby relieving HK2 inhibition and promoting glycolytic metabolism and tumor progression. The EZH2/miR-152/HK2 regulatory axis plays a critical role in lung cancer progression by modulating glycolysis and malignant phenotypes. Targeting this pathway may provide promising therapeutic strategies and potential diagnostic or prognostic biomarkers for lung cancer.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: